CAS: 199463-33-7 - Revaprazan
Formula:C22H23FN4
InChI:InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26)
InChI key:InChIKey=LECZXZOBEZITCL-UHFFFAOYSA-N
SMILES:FC1=CC=C(C=C1)NC=2N=C(C(=C(N2)C)C)N3CCC=4C=CC=CC4C3C
- Sinonimi:
- Revaprazan
- 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine
- YH 1885 free base
- 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-
- SB 641257
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Revaprazan REF: IN-DA00BHJSCAS: 199463-33-7 | 99% | Prezzo su richiesta | Mar 10 Dic 24 |
 | Revaprazan REF: TM-T20660CAS: 199463-33-7 | 98% | 1.418,00 €~2.325,00 € | Lun 16 Dic 24 |
 | Revaprazan REF: 3D-ZHA46333CAS: 199463-33-7 | Min. 95% | Prezzo su richiesta | Mar 21 Gen 25 |
Ref: IN-DA00BHJS
| 5mg | 121,00 € | ||
| 25mg | 306,00 € | ||
| 100mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
Revaprazan
CAS:199463-33-7
Revaprazan: novel, K⁺-competitive acid blocker; reversibly halts gastric H⁺/K⁺-ATPase; rivals PPIs in acid reduction.
Formula:
C22H23FN4
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
362.44
Ref: TM-T20660
| 25mg | 1.418,00 € | ||
| 50mg | 1.832,00 € | ||
| 100mg | 2.325,00 € |
Consegna stimata in Stati Uniti, il Lunedì 16 Dicembre 2024
Revaprazan
CAS:199463-33-7
Revaprazan hydrochloride is the salt form of Revaprazan which is concentrated in the gastric parietal …
Formula:
C22H23FN4
Purezza:
Min. 95%
Peso molecolare:
362.4 g/mol
Ref: 3D-ZHA46333
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
